Biomarkers in Obesity: Serum Myeloperoxidase and Traditional Cardiac Risk Parameters.

@article{Borato2016BiomarkersIO,
  title={Biomarkers in Obesity: Serum Myeloperoxidase and Traditional Cardiac Risk Parameters.},
  author={Danielle Cristyane K Borato and Gisele Chibinski Parabocz and Josimara T. Ribas and H P Netto and F C Erdmann and L D Wiecheteck and Francine Alessandra Manente and L R de Almeida Mello and Caroline Bell{\'o} and F{\'a}bio Andr{\'e} dos Santos and Luciana Maria Borba and Jos{\'e} Carlos Rebuglio Vellosa},
  journal={Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association},
  year={2016},
  volume={124 1},
  pages={
          49-54
        }
}
BACKGROUND Chronic low-grade inflammation, combined with traditional cardiovascular risk factors, is common in obesity, providing systemic inflammation that is associated with increased cardiovascular risk. Studies have shown serum mieloperoxidase as a potential biomarker and its clinical applicability for evaluating cardiovascular risk. This study aimed to evaluate the MPO in obese individuals, with or without systemic inflammation and potential cardiovascular risk, as well as correlating MPO… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Cardiac Risk Biomarkers in Obesity .

  • DC KBorato
  • Exp Clin Endocrinol Diabetes
  • 2016